Works matching IS 10648542 AND DT 2022 AND VI 31 AND IP 6


Results: 14
    1
    2

    Defining Quality Tolerance Limits and Key Risk Indicators for Timely Risk Detection: Series Part 1: Introduction and the relationship between QTL and KRI, with reflections from early adopters on emerging best practices.

    Published in:
    Applied Clinical Trials, 2022, v. 31, n. 6, p. 28
    By:
    • Dorricott, Keith;
    • Young, Steve;
    • Sullivan, Linda B.;
    • Cunningham, Maureen;
    • Czernik, Adam;
    • Douglass, Kevin;
    • Johnson, Todd;
    • Klindworth, Olgica;
    • Kurien, Crupa;
    • Lombardo, Kim;
    • Pilbrow, Gillian;
    • Sam, Leslie M.;
    • Stallcup, Kristin;
    • Sugiura, Yumi;
    • Sahores, Macarena
    Publication type:
    Article
    3
    4
    6

    Redefining Patient-Centricity: Exploring the Next Best in People, Processes and Technology for the Future of Decentralized Clinical Trials: How patient-centric initiatives guide the clinical drug development Sponsored by process towards increased inclusivity and diversity, patient convenience, safety, research relevance, and ease of use

    Published in:
    Applied Clinical Trials, 2022, v. 31, n. 6, p. 12
    By:
    • Kallsen, Kimberley;
    • O'Neill, Peter;
    • Ousmanou, Aliou;
    • Patil, Bhausaheb;
    • Preciado, Katy;
    • Price, Jeremy;
    • Sanford, Kelly;
    • Sayers, Rebecca;
    • Shaw, Katie;
    • Sigman, Jeff
    Publication type:
    Article
    7
    8
    9
    10
    11

    MORE KIDS DATA.

    Published in:
    Applied Clinical Trials, 2022, v. 31, n. 6, p. 6
    By:
    • Wechsler, Jill
    Publication type:
    Article
    12
    13
    14

    EMERGING TECHNOLOGY.

    Published in:
    Applied Clinical Trials, 2022, v. 31, n. 6, p. 3
    By:
    • Hennessy Jr., Mike
    Publication type:
    Article